CanadaBis Capital (CANB.H) AI Stock Analysis

CanadaBis Capital

(TSXV:CANB.H)

Select Model

Rating:41Neutral

Price Target:CAD 0.01▼(-6.67% Downside)

Action:reiterated

Date:08/04/26

The score is weighed down primarily by weak financial performance—especially inconsistent and recently negative operating/free cash flow, declining revenue, and a return to net losses—raising funding and durability risks. Technicals add pressure with the stock trading below key moving averages and no strong momentum signal. Valuation does not offset these risks due to a negative P/E and no dividend data.

Positive Factors

Solid Gross MarginA still-solid gross margin provides some underlying product economics and may help the company recover profitability if revenue stabilizes and operating costs are better controlled.

Negative Factors

Revenue DeclinesTwo consecutive years of declining revenue weaken visibility and suggest that prior growth has not yet become durable. Sustained contraction could reduce scale benefits and make a return to profitability more difficult.

CanadaBis Capital (CANB.H) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 2.07M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -1.6
Beta (1Y): -1.01
Revenue Growth: ―
EPS Growth: ―
Country: Canada
Employees: 0
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

CanadaBis Capital Business Overview & Revenue Model

Company Description

CanadaBis Capital Inc. is a Canadian firm specializing in the production and distribution of recreational cannabis and its extracted forms. The organization's business activities are divided into three principal divisions: Cultivation and Wholesale,...

CanadaBis Capital Financial Statement Overview

Summary

Financials are weak overall: revenue declined in 2024 and 2025 after prior growth, profitability deteriorated into a 2025 net loss, and cash flow is the biggest issue with negative operating and free cash flow in 2024–2025 (and other recent periods). The balance sheet is only moderate, with leverage rising and equity declining, reducing flexibility.

Income Statement

46Neutral

Balance Sheet

52Neutral

Cash Flow

24Negative

Financial statement breakdown
Breakdown	TTM	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021
Income Statement
Total Revenue	16.90M	16.90M	17.95M	22.22M	11.67M	6.87M
Gross Profit	7.33M	6.98M	8.82M	11.78M	5.57M	2.52M
EBITDA	800.06K	800.05K	2.09M	5.68M	1.57M	-1.81M
Net Income	-835.20K	-835.20K	600.28K	4.44M	608.33K	-2.68M
Balance Sheet
Total Assets	24.54M	24.54M	24.55M	22.96M	15.48M	13.28M
Cash, Cash Equivalents and Short-Term Investments	831.06K	831.06K	1.68M	3.23M	144.88K	849.50K
Total Debt	7.75M	7.75M	6.44M	7.31M	7.82M	8.44M
Total Liabilities	17.83M	17.83M	16.45M	15.62M	12.84M	11.46M
Stockholders Equity	6.62M	6.62M	8.00M	7.25M	2.54M	1.73M
Cash Flow
Free Cash Flow	-3.37M	-3.37M	-594.48K	4.57M	-292.54K	-1.96M
Operating Cash Flow	-3.20M	-3.20M	-256.31K	5.55M	-82.77K	-1.81M
Investing Cash Flow	-169.65K	-169.65K	-328.33K	-965.82K	-209.77K	122.77K
Financing Cash Flow	2.52M	2.52M	-962.02K	-1.50M	-412.09K	2.37M

CanadaBis Capital Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TSE:CANB.H against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TSE:CVGR	41Neutral	CAD 2.32M	-1.69	64.32%	―	―	-26.62%
TSE:CANB.H	41Neutral	CAD 2.07M	-1.65	-19.04%	―	―	―
TSE:CDVA	41Neutral	CAD 2.75M	-1.04	43.99%	―	-6.27%	44.49%

* General Sector Average

Performance Comparison

TSE:CANB.H and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:CANB.H	CanadaBis Capital, Inc.	0.01	-0.03	-62.50%
TSE:BAMM	Body & Mind	0.03	0.00	0.00%
TSE:CVGR	City View Green Holdings, Inc.	0.03	-0.04	-53.85%
TSE:CDVA	CordovaCann Corp	0.03	-0.00	-16.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 04, 2026

CanadaBis Capital AI Stock Analysis